FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304192989> ?p ?o ?g. }

• W4304192989 endingPage "659" @default.
• W4304192989 startingPage "651" @default.
• W4304192989 abstract "Introduction Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenemia, a quite common heterogenous endocrine/hormonal disorder, and accompanied by elevated androgen level, menstrual irregularity, and hirsutism. The consequences include infertility or miscarriage. It is a challenging problem to the physicians. In a one-arm, non-randomized preliminary investigation in fifty premenopausal women, we demonstrated the efficacy of Furocyst®, a patented, standardized Trigonella foenum-graecum extract, in ameliorating the symptoms of PCOS over a period of 90 consecutive days.Objective In the present study, a double-blind, two-arm, single-center, randomized, comparative study was conducted to assess the efficacy of Furocyst® (2 capsules of 500 mg/day) in 208 pre-menopausal women diagnosed with PCOS.Methods Ethical committee approval was obtained. A total of 208 subjects (placebo = 95; Furocyst® = 113; age:18-45 years, BMI < 42 kg/m2) completed the investigation. The comparative efficacy of placebo and Furocyst® was assessed on the number of cysts, ovarian volume, hirsutism, LH:FSH ratio, titer of TSH, SHBG, prolactin and free testosterone. Key clinical parameters such as fasting blood glucose levels, HOMA Index, cholesterol, LDL, and triglyceride levels, as well as total blood chemistry were also investigatedResults Furocyst® supplementation significantly reduced the number of cysts, ovarian volume, and hirsutism levels, as well as normalized the menstrual cycle in Furocyst®-treated subjects as compared to placebo group. Furocyst® significantly reduced luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels, and thyroid stimulating hormone (TSH) levels, and reduced the prolactin and SHBG levels. Furocyst® significantly reduced the fasting blood glucose levels, HOMA Index, cholesterol, LDL, and triglyceride levels as compared to the placebo group, while the free testosterone levels were significantly decreased in the Furocyst® group.Conclusion The studies collectively demonstrated the efficacy of Furocyst® as a safe, natural phytochemical-based formulation to alleviate the symptoms of PCOS. No significant adverse events were observed." @default.
• W4304192989 created "2022-10-11" @default.
• W4304192989 creator A5001862236 @default.
• W4304192989 creator A5013575296 @default.
• W4304192989 creator A5015593138 @default.
• W4304192989 creator A5019498762 @default.
• W4304192989 creator A5029925686 @default.
• W4304192989 creator A5081378711 @default.
• W4304192989 creator A5082832074 @default.
• W4304192989 creator A5090763733 @default.
• W4304192989 date "2022-10-11" @default.
• W4304192989 modified "2023-09-29" @default.
• W4304192989 title "Efficacy of a Proprietary Fenugreek Seed Extract (<i>Trigonella foenum-graecum</i>, Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): a Randomized, Double-Blind, Placebo-Controlled Study" @default.
• W4304192989 cites W1121887005 @default.
• W4304192989 cites W1647961127 @default.
• W4304192989 cites W1925133947 @default.
• W4304192989 cites W1975207893 @default.
• W4304192989 cites W2014499597 @default.
• W4304192989 cites W2016069630 @default.
• W4304192989 cites W2023342349 @default.
• W4304192989 cites W2033826262 @default.
• W4304192989 cites W2036919886 @default.
• W4304192989 cites W2050593976 @default.
• W4304192989 cites W2053931927 @default.
• W4304192989 cites W2054348561 @default.
• W4304192989 cites W2055243538 @default.
• W4304192989 cites W2084516758 @default.
• W4304192989 cites W2088854431 @default.
• W4304192989 cites W2093484637 @default.
• W4304192989 cites W2095962977 @default.
• W4304192989 cites W2109114706 @default.
• W4304192989 cites W2114949397 @default.
• W4304192989 cites W2130223496 @default.
• W4304192989 cites W2145682515 @default.
• W4304192989 cites W2152927657 @default.
• W4304192989 cites W2169817572 @default.
• W4304192989 cites W2278769514 @default.
• W4304192989 cites W2560636839 @default.
• W4304192989 cites W2727251886 @default.
• W4304192989 cites W2759642356 @default.
• W4304192989 cites W2803290954 @default.
• W4304192989 cites W2913866801 @default.
• W4304192989 cites W2945557565 @default.
• W4304192989 cites W2949825098 @default.
• W4304192989 cites W2957616322 @default.
• W4304192989 cites W2981768114 @default.
• W4304192989 cites W2983019515 @default.
• W4304192989 cites W3048756020 @default.
• W4304192989 cites W3087299746 @default.
• W4304192989 cites W3091901552 @default.
• W4304192989 cites W3113549027 @default.
• W4304192989 cites W3135250920 @default.
• W4304192989 cites W3165437656 @default.
• W4304192989 cites W3206391187 @default.
• W4304192989 cites W3209872776 @default.
• W4304192989 doi "https://doi.org/10.1080/27697061.2022.2126410" @default.
• W4304192989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36219198" @default.
• W4304192989 hasPublicationYear "2022" @default.
• W4304192989 type Work @default.
• W4304192989 citedByCount "0" @default.
• W4304192989 crossrefType "journal-article" @default.
• W4304192989 hasAuthorship W4304192989A5001862236 @default.
• W4304192989 hasAuthorship W4304192989A5013575296 @default.
• W4304192989 hasAuthorship W4304192989A5015593138 @default.
• W4304192989 hasAuthorship W4304192989A5019498762 @default.
• W4304192989 hasAuthorship W4304192989A5029925686 @default.
• W4304192989 hasAuthorship W4304192989A5081378711 @default.
• W4304192989 hasAuthorship W4304192989A5082832074 @default.
• W4304192989 hasAuthorship W4304192989A5090763733 @default.
• W4304192989 hasConcept C126322002 @default.
• W4304192989 hasConcept C134018914 @default.
• W4304192989 hasConcept C142724271 @default.
• W4304192989 hasConcept C204787440 @default.
• W4304192989 hasConcept C27081682 @default.
• W4304192989 hasConcept C2776371013 @default.
• W4304192989 hasConcept C2776405666 @default.
• W4304192989 hasConcept C2777391703 @default.
• W4304192989 hasConcept C2777688143 @default.
• W4304192989 hasConcept C2777911890 @default.
• W4304192989 hasConcept C2778575703 @default.
• W4304192989 hasConcept C2779064019 @default.
• W4304192989 hasConcept C2779234561 @default.
• W4304192989 hasConcept C2779279165 @default.
• W4304192989 hasConcept C2779279991 @default.
• W4304192989 hasConcept C2779306644 @default.
• W4304192989 hasConcept C30092816 @default.
• W4304192989 hasConcept C3018442814 @default.
• W4304192989 hasConcept C54355233 @default.
• W4304192989 hasConcept C71315377 @default.
• W4304192989 hasConcept C71924100 @default.
• W4304192989 hasConcept C86803240 @default.
• W4304192989 hasConceptScore W4304192989C126322002 @default.
• W4304192989 hasConceptScore W4304192989C134018914 @default.
• W4304192989 hasConceptScore W4304192989C142724271 @default.
• W4304192989 hasConceptScore W4304192989C204787440 @default.
• W4304192989 hasConceptScore W4304192989C27081682 @default.
• W4304192989 hasConceptScore W4304192989C2776371013 @default.
• W4304192989 hasConceptScore W4304192989C2776405666 @default.

• next